Genetec expect price gap up for a fantastic Q3 result with Q3 EPS 20 Sen and 9 mth YTD EPS of 18.1 Sen
Valuation of RM2 to RM2.50 with PE range of 8 to 10.
Genetec is due for rerating given its improvement in top and bottom line in Q3 and also its recent announcement on 4 Feb 2020 on securing new orders of RM38.5 mil for its new financial year ended 31 March 2021.
At 163 Sen, it is currently trading on historical PE 11.8 based on FY 2019 EPS of 13.82 Sen and forward PE 6.52 using a projected EPS 25 Sen for FY2020. Based on our projected FY 2020 EPS of 25 Sen ( 9 mth YTD EPS is 18.1 Sen) , using PE 8 to 12 would give GENETEC a valuation range of RM2.00 to RM2.50.
For 9 mth YTD FY 2020 the Co recorded a revenue of RM72 mil (9 mth YTD FY 2019 RM82.8 mil) and a net profit of RM7.3 mil (9 mth YTD FY 2019 RM9.7 mil) with an EPS of 18.1 Sen (FY 2019 23.45 Sen).
Note that in FY 2019, there was an impairment of RM5 mil goodwill written off in Q4 FY 2019 turning it into a net loss after tax of RM 3.7 mil for Q4 and FY 2019 result with a lower profit of RM6 mil with EPS 13.82 Sen
REVIEW OF PERFORMANCE
For the current quarter Q3 ended 31 December 2019, the Group recorded a revenue of RM40.1 million, an increase of 16.2% or RM5.6 million as compared to a revenue of RM34.5 million recorded in the preceding corresponding quarter ended 31 December 2018.
The Group recorded a net profit before tax of RM8.1 million (NPAT RM8.1 mil with EPS of 20 Sen) for the current quarter under review as compared to a net profit before tax of RM5.0 million (NPAT RM5.0 mil with EPS of 12.4 Sen) in the preceding corresponding quarter ended 31 December 2018.The increase in net profit before tax was mainly attributable to higher sales volume achieved and improved operational efficiency.
He is the biggest shareholder and a non executive director, not the key persons that run day to day operation. All the top 3 shareholders (and they are in the BOD) are increasing their shareholding in the company in the last 6 months. They wont do that unless they have confidence in the business.
Talking about history about this stock. It was once a darling stock back in 2015/2016. During the peak time, the top shareholder reduced his holding quite significantly before the price crash. After that, there was a reverse split (10:1).
Now, all the top 3 shareholders are increasing their shareholding again. However, the main reason I am in is because I think they are in the right business; not entirely due the insider activities. I see it as potential turn-around stock.
I have not looked at the QR in detailed, but the business was impacted due to COVID19, right? and also some impairment loss....
Anyway, there are still a lot uncertainties in the market. Consider selling or reducing position if you are worried.
cola they have been in the right business many years ago, with CKV leadership the results were mixed but still generating not too bad profits. Going forward, without CKV can they still performed the mixed results as previous or they are able to outperform in the semicon related market ?
Xcaliber,You still dare to trust those gurus recommendation?? WTVIP on 23/6 posted"Genetec director keep on buying what u afraid of"? But on 24/6 posted "what we learn from Genetec results,as a trader we need to adhere to cut loss point 1.49" U-tun like politicians la..hahaha
@Dkk08 Not trusting the So called Stock Guru (Warrior Traders VIP pulak)... all these con men strategy and pump and dump......Luckily I didn't pay for their course...
This is con artist job... Up already quick Chao first before the so called Warrior Trader get out before you... Don't be conned by WT in tricking you to enter.. Once you enter.. WT will sell
Genetec Technology is designing and building of customized factory automation equipment and integrated vision inspection systems. The company operates solely in the Industrial Automation segment. The company serves a diverse set of markets including automotive, hard disk drive industries, semiconductor, and electronics.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
RogerTan901111
184 posts
Posted by RogerTan901111 > 2020-02-26 21:04 | Report Abuse
Good results